| Metric | Q4 2021 | Q3 2021 | Q4 2020 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $40.3B | — | $32.8B | — | 23.0% |
| Op. Income | -$57M | — | $87M | — | -165.9% |
| Gross Margin | 13.5% | — | 13.9% | — | -0.4pp |
| Net Margin | -1.9% | — | 10.8% | — | -12.7pp |
| EPS (Diluted) | $-0.49 | — | $2.22 | — | -121.9% |
| Free Cash Flow | $515M | — | $163M | — | 214.9% |
| Item | Amount |
|---|---|
| REVENUE | $40.3B |
| Cost of Revenue | $34.9B |
| GROSS PROFIT | $5.4B |
| R&D Expenses | $600M |
| Selling & Marketing | $2.0B |
| General & Administrative | $546M |
| SG&A Expenses | $2.5B |
| Other Expenses | $2.4B |
| Operating Expenses | $5.5B |
| Cost & Expenses | $40.4B |
| OPERATING INCOME | -$57M |
| Interest Expense | $10M |
| Other Income/Expenses | -$693M |
| INCOME BEFORE TAX | -$750M |
| Income Tax Expense | $27M |
| Net Income from Continuing Ops | -$777M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | -$756M |
| Net Income Deductions | -$1M |
| BOTTOM LINE NET INCOME | -$755M |
| D&A | $229M |
| EBIT | -$685M |
| EBITDA | -$456M |
| EPS | -$0 |
| EPS Diluted | -$0 |
| Item | Amount |
|---|---|
| Net Income | -$755M |
| Depreciation & Amortization | $334M |
| Stock-Based Compensation | $441M |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | $4.0B |
| Change in Working Capital | -$3.1B |
| OPERATING CASH FLOW | $946M |
| Capital Expenditure | -$431M |
| Acquisitions (Net) | -$47M |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | -$2.3B |
| NET CASH FROM INVESTING | -$2.7B |
| Net Debt Issuance | $0 |
| Common Stock Repurchased | -$767M |
| Common Dividends Paid | $0 |
| Other Financing Activities | $266M |
| NET CASH FROM FINANCING | -$501M |
| FREE CASH FLOW | $515M |
| Net Change in Cash | -$2.5B |
| Item | Amount |
|---|---|
| Cash & Equivalents | $1.8B |
| Short-Term Investments | $2.6B |
| Net Receivables | $399M |
| Inventory | $1.8B |
| Other Current Assets | $263M |
| TOTAL CURRENT ASSETS | $6.9B |
| PP&E (Net) | $1.3B |
| Goodwill | $285M |
| Intangible Assets | $134M |
| Long-Term Investments | $1.9B |
| Tax Assets | $25M |
| Other Non-Current Assets | $828M |
| TOTAL NON-CURRENT ASSETS | $4.5B |
| TOTAL ASSETS | $11.4B |
| Account Payables | $3.2B |
| Short-Term Debt | $261M |
| Deferred Revenue | $747M |
| Other Current Liabilities | $602M |
| TOTAL CURRENT LIABILITIES | $5.1B |
| Long-Term Debt | $215M |
| Deferred Revenue NC | $30M |
| Deferred Tax Liabilities | $43M |
| Other Non-Current Liabilities | $41M |
| TOTAL NON-CURRENT LIABILITIES | $644M |
| TOTAL LIABILITIES | $5.7B |
| Common Stock | $0 |
| Additional Paid-In Capital | $4.2B |
| Retained Earnings | $775M |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | -$103M |
| Other Equity | -$68M |
| TOTAL STOCKHOLDERS' EQUITY | $4.8B |
| Minority Interest | $868M |
| TOTAL EQUITY | $5.7B |
| TOTAL LIABILITIES & EQUITY | $11.4B |
| Total Debt | $790M |
| Net Debt | -$968M |
